CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas.
Kelly N FitzgeraldAndres E QuesadaGottfried von KeudellSandeep RajNatasha E LewisAhmet DoganGilles SallesMaria Lia PalombaPublished in: Leukemia & lymphoma (2021)